↓ Skip to main content

Dove Medical Press

Mood disorders and complementary and alternative medicine: a literature review

Overview of attention for article published in Neuropsychiatric Disease and Treatment, May 2013
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (97th percentile)
  • High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

news
4 news outlets
blogs
1 blog
policy
1 policy source
twitter
19 X users
facebook
8 Facebook pages
wikipedia
1 Wikipedia page
googleplus
1 Google+ user
video
3 YouTube creators

Citations

dimensions_citation
116 Dimensions

Readers on

mendeley
495 Mendeley
Title
Mood disorders and complementary and alternative medicine: a literature review
Published in
Neuropsychiatric Disease and Treatment, May 2013
DOI 10.2147/ndt.s43419
Pubmed ID
Authors

Naseem Akhtar Qureshi, Abdullah Mohammed Al-Bedah

Abstract

Mood disorders are a major public health problem and are associated with considerable burden of disease, suicides, physical comorbidities, high economic costs, and poor quality of life. Approximately 30%-40% of patients with major depression have only a partial response to available pharmacological and psychotherapeutic interventions. Complementary and alternative medicine (CAM) has been used either alone or in combination with conventional therapies in patients with mood disorders. This review of the literature examines evidence-based data on the use of CAM in mood disorders. A search of the PubMed, Medline, Google Scholar, and Quertile databases using keywords was conducted, and relevant articles published in the English language in the peer-reviewed journals over the past two decades were retrieved. Evidence-based data suggest that light therapy, St John's wort, Rhodiola rosea, omega-3 fatty acids, yoga, acupuncture, mindfulness therapies, exercise, sleep deprivation, and S-adenosylmethionine are effective in the treatment of mood disorders. Clinical trials of vitamin B complex, vitamin D, and methylfolate found that, while these were useful in physical illness, results were equivocal in patients with mood disorders. Studies support the adjunctive role of omega-3 fatty acids, eicosapentaenoic acid, and docosahexaenoic acid in unipolar and bipolar depression, although manic symptoms are not affected and higher doses are required in patients with resistant bipolar depression and rapid cycling. Omega-3 fatty acids are useful in pregnant women with major depression, and have no adverse effects on the fetus. Choline, inositol, 5-hydroxy-L-tryptophan, and N-acetylcysteine are effective adjuncts in bipolar patients. Dehydroepiandrosterone is effective both in bipolar depression and depression in the setting of comorbid physical disease, although doses should be titrated to avoid adverse effects. Ayurvedic and homeopathic therapies have the potential to improve symptoms of depression, although larger controlled trials are needed. Mind-body-spirit and integrative medicine approaches can be used effectively in mild to moderate depression and in treatment-resistant depression. Currently, although CAM therapies are not the primary treatment of mood disorders, level 1 evidence could emerge in the future showing that such treatments are effective.

X Demographics

X Demographics

The data shown below were collected from the profiles of 19 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 495 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 4 <1%
United States 3 <1%
Germany 1 <1%
Czechia 1 <1%
Australia 1 <1%
Canada 1 <1%
Brazil 1 <1%
Unknown 483 98%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 89 18%
Student > Master 70 14%
Researcher 62 13%
Student > Doctoral Student 38 8%
Student > Ph. D. Student 37 7%
Other 104 21%
Unknown 95 19%
Readers by discipline Count As %
Medicine and Dentistry 132 27%
Psychology 62 13%
Nursing and Health Professions 50 10%
Agricultural and Biological Sciences 33 7%
Pharmacology, Toxicology and Pharmaceutical Science 27 5%
Other 79 16%
Unknown 112 23%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 60. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 November 2023.
All research outputs
#719,408
of 25,654,806 outputs
Outputs from Neuropsychiatric Disease and Treatment
#90
of 3,142 outputs
Outputs of similar age
#4,986
of 204,979 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#3
of 53 outputs
Altmetric has tracked 25,654,806 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,142 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.4. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 204,979 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 53 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 94% of its contemporaries.